Since LVs can transduce a wide array of cells, support long-term gene expression, and be modified to enhance cell targeting, LVs are a powerful modality to deliver life-long therapeutic proteins.
Lastly, with the increasing availability of radiotracers and novel compounds for molecular and physiological assessment, including labelling of target cells and compounds that target particular cell lines or processes, the combination of these powerful modalities may result in significant advances for research (and potentially clinical) purposes.
Therapeutic monoclonal antibodies (TmAbs) that block tumor necrosis factor are powerful modalities in the treatment of various inflammatory diseases, but both chimeric and human TmAbs can induce anti-TmAb antibodies.
PAT, as an emerging powerful modality, has the capability to image the structural and functional information of biological tissues with high resolution and satisfactory imaging depth [ 1– 4].
This further highlights its potential to be a powerful modality for assessing tissue flaps and preventing their failure.
Currently, we use IVUS as a powerful adjunct in combination with other modalities to increase our understanding of vessel architecture and assist in the management of complex vascular pathology.
These can offer powerful benefits, but at times there are kinder, gentler modalities to get the same job done.
This sustained and controllable growth factor delivery system, with independently controllable physical and cell adhesive properties, may provide a powerful modality for a variety of therapeutic applications.
Multispectral optoacoustic tomography (MSOT) is a powerful modality that allows high-resolution imaging of photo-absorbers deep within tissue, beyond the classical depth and resolution limitations of conventional optical imaging.
Multifunctional nanoparticles (NPs) that enable diagnostic imaging and therapeutic drug delivery are rapidly emerging as a powerful modality in cancer therapy.
